Tomorrow Investor

Volatus Aerospace Launches SKYDRA™, a Counter-Drone Platform

Launch of SKYDRA™ Counter-Drone Platform by Volatus Aerospace | GlobeNewsWire

MONTRÉAL, March 02, 2026 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSXV: FLT | OTCQX: TAKOF | FSE: ABB.F) (“Volatus” or the “Company”), a Canadian aerospace and defence company delivering integrated uncrewed systems and mission-critical operational services, today announced the launch of SKYDRA™, the Company’s first Software-as-a-Service (SaaS) platform designed to support counter-unmanned aircraft system (CUAS) operational planning and simulation. SKYDRA™ introduces a digital capability within the Volatus defence portfolio designed to support structured planning, simulation, and readiness exercises for counter-drone operations.

This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.

Brief Summary

Volatus Aerospace has unveiled SKYDRA™, a cutting-edge Software-as-a-Service (SaaS) platform tailored for counter-drone operations. This innovative solution enhances operational readiness and planning for defense against unmanned aerial threats.

  • Integrated Solutions: Supports structured operational planning.
  • Simulation Capabilities: Provides realistic training scenarios.
  • Enhanced Readiness: Aims to improve responses to drone incursions.
  • Market Expansion: Positions Volatus at the forefront of CUAS technology.

Why it matters: With growing concerns over drone-related threats, SKYDRA™ offers critical support to operational planning, enhancing national security measures effectively.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.